Skip to main content

Animations

MJFF Publications

5181 - 5190 of 8801 Results
Title
Year
  • Year
  • 2025
  • 2022
  • 2025
  • 2014
  • 2024
  • 2014
  • 2020
  • 2015
  • 2024
  • 2023
  • Summary Details
    RESTRICTED
    Title: Protocol for live imaging of axonal transport in iPSC-derived iNeurons
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xpro.2024.103556
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13451
    Citation Count: 24
  • Summary Details
    OPEN
    Title: A robotic and virtual testing platform highlighting the promise of soft wearable actuators for wrist tremor suppression
    Journal Name: Device
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.device.2025.100719
    Citation Count: 1
  • Summary Details
    OPEN
    Title: MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a
    Journal Name: Journal of Neuroimmunology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jneuroim.2014.11.004
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Intracellular delivery of Parkin-RING0-based fragments corrects Parkin-induced mitochondrial dysfunction through interaction with SLP-2
    Journal Name: Journal of Translational Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12967-024-04850-3
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2014.09.013
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Reduced complement of dopaminergic neurons in the substantia nigra pars compacta of mice with a constitutive “low footprint” genetic knockout of alpha-synuclein
    Journal Name: Molecular Brain
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13041-020-00613-5
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Deep clinical and neuropathological phenotyping of Pick disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24559
    Citation Count: 173
  • Summary Details
    OPEN
    Title: MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00083-8
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Association of liver fibrosis with cognitive decline in Parkinson’s disease
    Journal Name: Journal of Clinical Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jocn.2023.11.019
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.